Trials / Conditions / Ovarian Serous Surface Papillary Adenocarcinoma
Ovarian Serous Surface Papillary Adenocarcinoma
5 registered clinical trials studyying Ovarian Serous Surface Papillary Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube NCT02283658 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, NCT02101775 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Canc NCT01116648 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Research Study in Patients With Advanced Ovarian Epithelial Cancer NCT00053235 | Gynecologic Oncology Group | — |